Lung Cancers Completed Phase 2 Trials for Budesonide (DB01222)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Completed2 IdentifierTitlePurposeDrugs
NCT00321893Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerPrevention
NCT00005880Budesonide in Treating Former and Current Smokers With Bronchial DysplasiaPrevention